Shares in British pharmaceutical firm Shire soared as much as 13% after the company rejected a third takeover bid from US drug giant AbbVie. AbbVie had offered £27bn ($46bn) for Shire, which is known primarily as a maker of drugs for rare diseases. via Pocket http://ift.tt/1ifeA3d
No comments:
Post a Comment